The weekly litigation news digest is live. Subscribe now

IP Verse

Pegylated L-Asparaginase - EP2451486

The patent EP2451486 was granted to Alize Pharma II on Jan 18, 2023. The application was originally filed on Jul 6, 2010 under application number EP10730170A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2451486

ALIZE PHARMA II
Application Number
EP10730170A
Filing Date
Jul 6, 2010
Status
Patent Maintained As Amended
Dec 16, 2022
Publication Date
Jan 18, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MATHYS & SQUIREFeb 2, 2018TITMUSADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2002065397
DESCRIPTIONUS2003114647
DESCRIPTIONUS2009054590
DESCRIPTIONUS4179337
DESCRIPTIONUS4670417
DESCRIPTIONUS5252714
DESCRIPTIONUS5672662
DESCRIPTIONUS5766897
DESCRIPTIONUS6113906
DESCRIPTIONUS7419600
DESCRIPTIONWO2004083258
DESCRIPTIONWO2007103290
EXAMINATIONUS5672662
INTERNATIONAL-SEARCH-REPORTWO03018742

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents